Background: To date, world widely, only a couple of papers have reported the association between pulmonary tuberculosis, Coronavirus disease 2019 (COVID-19) and pregnancy, and none of these reports was from sub-Saharan Africa where tuberculosis is endemic. Objective: the main objective of this study is to describe the co-infection Pulmonary Tuberculosis and Severe COVID-19 in pregnant young Woman at the University Hospital of Kinshasa. Method: The report case is of a pregnant woman aged 19 (Pare 2, Gesture 2, Abortion 0) with no known significant medical history, at 32 weeks of gestation based last menstrual period She has benefited from clinic examination, biological examinations (Ziehl’s on sputum), a chest CT scan and a morphological ultrasound. Result: On admission, COVID-19 was the only working diagnosis. However, the persistent coughing prompted clinicians to request a Ziehl-Neelsen staining of sputum that revealed the diagnosis of pulmonary TB. The reverse-transcription polymerase chain reaction (RT-PCR)-confirmed COVID-19 infection and HIV serology negative. A contrast-enhanced chest computed tomography (CT) showed airspace disease involving the right upper lobar, right medial basal segment and left upper lobe in the background of diffuse micro-nodular opacities favored to represent military pulmonary tuberculosis. There were associated cystic bronchiectasis in bilateral upper lobe and bilateral small amount of pleural effusion. Aforementioned findings were favored to represent a secondary or reactivation tuberculosis. The obstetrical ultrasound showed a single live intrauterine pregnancy in breech presentation, estimated at 34 weeks 3 days of gestation without usual features including detectable congenital malformation. Conclusion: The outcome of a pregnant woman with simultaneous COVID-19 and pulmonary tuberculosis is improved when the diagnosis is made early and management is promptly initiated. This attitude also improves the fetal prognosis. In the context of the COVID-19, the association of COVID-19 and pulmonary tuberculosis, especially in immunocompromised patients should be considered.
Published in | International Journal of Medical Imaging (Volume 9, Issue 3) |
DOI | 10.11648/j.ijmi.20210903.13 |
Page(s) | 149-154 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Pulmonary Tuberculosis, COVID-19, Pregnancy, Immunocompromised, Sub-Saharan Africa
[1] | Chan J, Yuan S, Kok K-H, To K, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020; 395. doi: 10.1016/S0140-6736 (20)30154-9. |
[2] | Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020; 222 (5): 415-426. |
[3] | Yang H, Wang C, Poon LC. Novel coronavirus infection and pregnancy. Ultrasound Obstet Gynecol. 2020; 55 (4): 435-437. |
[4] | Dara M, Sotgiu G, Reichler MR, Chiang C-Y, Chee CBE, Migliori GB. New diseases and old threats: lessons from tuberculosis for the COVID-19 response. Int J Tuberc Lung Dis. 2020; 24 (5): 544-545. |
[5] | WHO. COVID-19: Considerations for tuberculosis (TB) care. World Health Organization (WHO) Information Note Tuberculosis and COVID-19. 2020. https://www.who.int/docs/default-source/documents/tuberculosis/infonote-tb-COVID-19.pdf. |
[6] | Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94: 91-95. |
[7] | Chen Y, Wang Y, Fleming J, Yu Y, Gu Y, Liu C, et al. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. 2020. Infectious Diseases (except HIV/AIDS) doi: 10.1101/2020.03.10.20033795. |
[8] | Lockdown: World's biggest lockdown to push 12 million into extreme poverty - The Economic Times. https: //economictimes.indiatimes.com/news/economy/indicators/worlds-biggest-lockdown-to-push-12-million-into-extreme-poverty/articleshow/76056756.cms. Accessed 1 May 2021. |
[9] | Udwadia ZF, Vora A, Tripathi AR, Malu KN, Lange C, Sara Raju R. COVID-19 -Tuberculosis interactions: When dark forces collide. Indian Journal of Tuberculosis. 2020; 67 (4, Supplement): S155-S162. |
[10] | de Castro MJ, Pardo-Seco J, Martinón-Torres F. Nonspecific (Heterologous) Protection of Neonatal BCG Vaccination Against Hospitalization Due to Respiratory Infection and Sepsis. Clin Infect Dis. 2015; 60 (11): 1611-1619. |
[11] | Arts RJW, Moorlag SJCFM, Novakovic B, Li Y, Wang S-Y, Oosting M, et al. BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host Microbe. 2018; 23 (1): 89-100. e5. |
[12] | A M, Mj R, K F, V R, Y L, Gh O. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv. 00: 00: 00.0. doi: 10.1101/2020.03.24.20042937. |
[13] | Machines used for testing drug-resistant TB can now be used for confirmation of COVID-19 cases. The Hindu. 2020. https: //www.thehindu.com/sci-tech/science/machines-used-for-testing-drug-resistant-tb-can-be-now-used-for-confirmation-of-COVID-19-cases/article31629602.ece. Accessed 1 May 2021. |
[14] | Stop TB Partnership. The potential impact of the COVID-19 response on tuberculosis in high-burden countries: a modelling analysis. 2020. http://www.stoptb.org/assets/documents/news/Modeling%20Report_1%20May%202020_FINAL.pdf. |
[15] | Murphy RA, Marconi VC, Gandhi RT, Kuritzkes DR, Sunpath H. Coadministration of lopinavir/ritonavir and rifampicin in HIV and tuberculosis co-infected adults in South Africa. PLoS One. 2012; 7 (9): e44793. |
[16] | Pandie M, Wiesner L, McIlleron H, Hughes J, Siwendu S, Conradie F, et al. Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB. J Antimicrob Chemother. 2016; 71 (4): 1037-1040. |
[17] | Hegewald MJ, Crapo RO. Respiratory physiology in pregnancy. Clin Chest Med. 2011; 32 (1): 1-13. |
[18] | Muyayalo KP, Huang D, Zhao S, Xie T, Mor G, Liao A. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes. Am J Reprod Immunol. 2020. doi: 10.1111/aji.13304. |
[19] | Brosnihan KB, Neves L a. A, Anton L, Joyner J, Valdes G, Merrill DC. Enhanced expression of Ang- (1-7) during pregnancy. Braz J Med Biol Res. 2004; 37 (8): 1255-1262. |
[20] | West CA, Sasser JM, Baylis C. The enigma of continual plasma volume expansion in pregnancy: critical role of the renin-angiotensin-aldosterone system. Am J Physiol Renal Physiol. 2016; 311 (6): F1125-F1134. |
[21] | Rasmussen SA, Jamieson DJ, Macfarlane K, Cragan JD, Williams J, Henderson Z, et al. Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health. 2009; 99 Suppl 2: S248-254. |
[22] | Trippella G, Ciarcià M, Ferrari M, Buzzatti C, Maccora I, Azzari C, et al. COVID-19 in Pregnant Women and Neonates: A Systematic Review of the Literature with Quality Assessment of the Studies. Pathogens. 2020; 9 (6). doi: 10.3390/pathogens9060485. |
[23] | Bothamley G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf. 2001; 24 (7): 553–565. |
APA Style
Frederick Tshibasu Tshienda, Tresor Mputsu, Ben Bepouka Izizag, Cynthia Minouche Bukumba, Angele Mbongo Tansia, et al. (2021). Co-infection Pulmonary Tuberculosis and Severe COVID-19 in a Pregnant Woman at the University Hospital of Kinshasa: A Case Report. International Journal of Medical Imaging, 9(3), 149-154. https://doi.org/10.11648/j.ijmi.20210903.13
ACS Style
Frederick Tshibasu Tshienda; Tresor Mputsu; Ben Bepouka Izizag; Cynthia Minouche Bukumba; Angele Mbongo Tansia, et al. Co-infection Pulmonary Tuberculosis and Severe COVID-19 in a Pregnant Woman at the University Hospital of Kinshasa: A Case Report. Int. J. Med. Imaging 2021, 9(3), 149-154. doi: 10.11648/j.ijmi.20210903.13
AMA Style
Frederick Tshibasu Tshienda, Tresor Mputsu, Ben Bepouka Izizag, Cynthia Minouche Bukumba, Angele Mbongo Tansia, et al. Co-infection Pulmonary Tuberculosis and Severe COVID-19 in a Pregnant Woman at the University Hospital of Kinshasa: A Case Report. Int J Med Imaging. 2021;9(3):149-154. doi: 10.11648/j.ijmi.20210903.13
@article{10.11648/j.ijmi.20210903.13, author = {Frederick Tshibasu Tshienda and Tresor Mputsu and Ben Bepouka Izizag and Cynthia Minouche Bukumba and Angele Mbongo Tansia and Daddy Mata-Mbemba and Madone Mandina Ndona and Joseph Bodi Mabiala and Jean Robert Makulo Risasi and Roger Mbungu Mwimba and Damien Mbanzulu Pita Nsonizau and Jean Marie Kayembe Ntumba and Benjamin Longo Mbenza}, title = {Co-infection Pulmonary Tuberculosis and Severe COVID-19 in a Pregnant Woman at the University Hospital of Kinshasa: A Case Report}, journal = {International Journal of Medical Imaging}, volume = {9}, number = {3}, pages = {149-154}, doi = {10.11648/j.ijmi.20210903.13}, url = {https://doi.org/10.11648/j.ijmi.20210903.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20210903.13}, abstract = {Background: To date, world widely, only a couple of papers have reported the association between pulmonary tuberculosis, Coronavirus disease 2019 (COVID-19) and pregnancy, and none of these reports was from sub-Saharan Africa where tuberculosis is endemic. Objective: the main objective of this study is to describe the co-infection Pulmonary Tuberculosis and Severe COVID-19 in pregnant young Woman at the University Hospital of Kinshasa. Method: The report case is of a pregnant woman aged 19 (Pare 2, Gesture 2, Abortion 0) with no known significant medical history, at 32 weeks of gestation based last menstrual period She has benefited from clinic examination, biological examinations (Ziehl’s on sputum), a chest CT scan and a morphological ultrasound. Result: On admission, COVID-19 was the only working diagnosis. However, the persistent coughing prompted clinicians to request a Ziehl-Neelsen staining of sputum that revealed the diagnosis of pulmonary TB. The reverse-transcription polymerase chain reaction (RT-PCR)-confirmed COVID-19 infection and HIV serology negative. A contrast-enhanced chest computed tomography (CT) showed airspace disease involving the right upper lobar, right medial basal segment and left upper lobe in the background of diffuse micro-nodular opacities favored to represent military pulmonary tuberculosis. There were associated cystic bronchiectasis in bilateral upper lobe and bilateral small amount of pleural effusion. Aforementioned findings were favored to represent a secondary or reactivation tuberculosis. The obstetrical ultrasound showed a single live intrauterine pregnancy in breech presentation, estimated at 34 weeks 3 days of gestation without usual features including detectable congenital malformation. Conclusion: The outcome of a pregnant woman with simultaneous COVID-19 and pulmonary tuberculosis is improved when the diagnosis is made early and management is promptly initiated. This attitude also improves the fetal prognosis. In the context of the COVID-19, the association of COVID-19 and pulmonary tuberculosis, especially in immunocompromised patients should be considered.}, year = {2021} }
TY - JOUR T1 - Co-infection Pulmonary Tuberculosis and Severe COVID-19 in a Pregnant Woman at the University Hospital of Kinshasa: A Case Report AU - Frederick Tshibasu Tshienda AU - Tresor Mputsu AU - Ben Bepouka Izizag AU - Cynthia Minouche Bukumba AU - Angele Mbongo Tansia AU - Daddy Mata-Mbemba AU - Madone Mandina Ndona AU - Joseph Bodi Mabiala AU - Jean Robert Makulo Risasi AU - Roger Mbungu Mwimba AU - Damien Mbanzulu Pita Nsonizau AU - Jean Marie Kayembe Ntumba AU - Benjamin Longo Mbenza Y1 - 2021/08/04 PY - 2021 N1 - https://doi.org/10.11648/j.ijmi.20210903.13 DO - 10.11648/j.ijmi.20210903.13 T2 - International Journal of Medical Imaging JF - International Journal of Medical Imaging JO - International Journal of Medical Imaging SP - 149 EP - 154 PB - Science Publishing Group SN - 2330-832X UR - https://doi.org/10.11648/j.ijmi.20210903.13 AB - Background: To date, world widely, only a couple of papers have reported the association between pulmonary tuberculosis, Coronavirus disease 2019 (COVID-19) and pregnancy, and none of these reports was from sub-Saharan Africa where tuberculosis is endemic. Objective: the main objective of this study is to describe the co-infection Pulmonary Tuberculosis and Severe COVID-19 in pregnant young Woman at the University Hospital of Kinshasa. Method: The report case is of a pregnant woman aged 19 (Pare 2, Gesture 2, Abortion 0) with no known significant medical history, at 32 weeks of gestation based last menstrual period She has benefited from clinic examination, biological examinations (Ziehl’s on sputum), a chest CT scan and a morphological ultrasound. Result: On admission, COVID-19 was the only working diagnosis. However, the persistent coughing prompted clinicians to request a Ziehl-Neelsen staining of sputum that revealed the diagnosis of pulmonary TB. The reverse-transcription polymerase chain reaction (RT-PCR)-confirmed COVID-19 infection and HIV serology negative. A contrast-enhanced chest computed tomography (CT) showed airspace disease involving the right upper lobar, right medial basal segment and left upper lobe in the background of diffuse micro-nodular opacities favored to represent military pulmonary tuberculosis. There were associated cystic bronchiectasis in bilateral upper lobe and bilateral small amount of pleural effusion. Aforementioned findings were favored to represent a secondary or reactivation tuberculosis. The obstetrical ultrasound showed a single live intrauterine pregnancy in breech presentation, estimated at 34 weeks 3 days of gestation without usual features including detectable congenital malformation. Conclusion: The outcome of a pregnant woman with simultaneous COVID-19 and pulmonary tuberculosis is improved when the diagnosis is made early and management is promptly initiated. This attitude also improves the fetal prognosis. In the context of the COVID-19, the association of COVID-19 and pulmonary tuberculosis, especially in immunocompromised patients should be considered. VL - 9 IS - 3 ER -